BMJ  2006;332:637-638 (18 March), doi:10.1136/bmj.38706.742731.47 (published 8 March 2006)

Research

Intramuscular gluteal injections in the increasingly obese population: retrospective study

¹ Jersey General Hospital, St Helier, Jersey JE2 3QS

Abstract

Aims To examine depth of subcutaneous fat at gluteal intramuscular injection sites.

Design Retrospective study.

Setting General hospital.

Participants 100 consecutive adults who had computed tomography of the pelvis.

Main outcome measures Minimum distance between the surface of the skin and the nearest edge of muscle at intramuscular injection sites.

Results 12 patients had a ventrogluteal site depth of more than 35 mm, the maximum depth of a green needle, and 26 had a ventrogluteal depth of more than 25 mm, the maximum depth of a blue needle. 43 patients had a dorsogluteal site depth of more than 35 mm, and 72 had a dorsogluteal depth of more than 25 mm. The intramuscular site was likely to be deeper in women.

Conclusion Standard green and blue needles do not reach the gluteal muscles in a considerable number of patients.

Introduction

Studies of intramuscular injections have shown differences in peak plasma concentrations of narcotics and in perceived pain relief, depending on gluteal or deltoid injection site.¹ Response levels to vaccination vary according to intramuscular injection site.² Different responses depending on site have also been noticed for injections of antibiotics,³ insulin, and lignocaine.⁴

Possible reasons for this variation in efficacy include different ratios of adipose to lean muscle tissue, greater blood flow in deltoid than gluteal muscle,⁵ and positional external compression of the gluteus. In a population that is increasingly overweight, these factors could become more exaggerated, leading overall to less effective intramuscular gluteal injections. Additionally, if the depth of fat is so great that the needle cannot reach the muscular layer in many patients, the average absorption of the drug in the population will be lower.

Method

Scans from 100 consecutive adults (39 men, 61 women; mean 47.8 (SD 11.3) years; range 22-65 years) who had computed tomography scans of the pelviswere included in the study. I used automated computed tomography callipers to determine the minimum distance between the surface of the skin and the nearest edge of muscle at the ventrogluteal and dorsogluteal injection sites. (To determine the ventrogluteal site, place the ball of the opposing hand on the greater trochanter and index finger on the anterior superior iliac crest; form a V with the middle finger; the injection site is within the V.⁶ The dorsogluteal site is the upper outer quadrant of the buttock.⁷) I also correlated the depth at both sites with age and sex of the patients.

What is already known on this topic The gluteal site can be less effective for intramuscular injections than other sites, such as deltoid What this study adds The gluteal muscles are beyond the reach of standard green and blue needles in a significant minority of patients

Results

The depth of adipose tissue at the ventrogluteal site ranged from 2.5 mm to 62.6 mm (mean 19.0 (12.8) mm). In 12 patients the depth was more than 35 mm, the extent of a green needle, and in 26 the depth was more than 25 mm, the extent of a blue needle. The depth at the dorsogluteal site ranged from 7.5 mm to 59.8 mm (mean 32.0 (10.5) mm). In 43 patients the depth was more than 35 mm, and in 72 the depth was more than 25 mm.

Age was not correlated with dorsogluteal depth, but increasing age was related to increasing ventrogluteal depth (P < 0.01, Pearson's correlation coefficient).

Site depth was markedly different in men and women. In the ventrogluteal site, 10 of 61 (16%) women had a depth of >35 mm and 22(36%) a depth of >25 mm, whereas 2 of 39 (5%) men had a depth of >35 mm and 4 (10%) of >25 mm. In the dorsogluteal site, 35 (57%) women had a depth of >35 mm and 55 (90%) of >25 mm, whereas 8 (21%) men had a depth of >35 mm and 17 (44%) of >25 mm. All differences between men and women were significant (P<0.01, ² test, except P<0.05 for ventrogluteal depth >35 mm).

Discussion

Due to the depth of fat, intramuscular injections with large (green) needles into the anterior gluteal site in this sample would be subcutaneous in 12% of patients (16% of women and 5% of men), and for injections with smaller (blue) needles in 26% (36% of women and 10% of men). In the posterior gluteal site, large needles will fail to reach muscle in 43% (57% of women and 21% of men), and small needles will fail in 72% (90% of women and 44% of men).

The number of patients used in this study was small, and they were recruited only from a local population and did not include the extremes of age. Although the depth of their gluteal intramuscular injection sites may vary from the national average, this study shows that in a significant minority of patients the standard green or blue needles, which are the normal method of delivery, will fail to reach muscle. In highly obese populations, the depth could be expected to be even greater than that shown here.

As previous studies have shown low efficacy of gluteal intramuscular injections, this route should be avoided for most drugs. If alternative routes are not possible, using longer needles should be considered.

---

This article was posted on bmj.com on 8 March 2006: http://bmj.com/cgi/doi/10.1136/bmj.38706.742731.47

Contributors: ACN is the sole contributor and is guarantor.

Funding: None.

Competing interests: None declared.

Ethical approval: Not required.

References

1. Grabinski P, Kaiko RF, Rogers AG, Houde RW. Plasma levels and analgesia following deltoid and gluteal injections of methadone and morphine. J Clin Pharmacol 1983;23: 48-55.[Abstract]
2. Lindsay KL, Herbert DA, Gitnick GL. Hepatitis B vaccine: low postvaccination immunity in hospital personnel given gluteal injections. Hepatology 1985;5: 1088-90.[Medline]
3. Vukonovich RA, Brannick LJ, Sugerman AA, Neiss ES. Sex differences in the intramuscular absorption and bioavailability of cephradine. Clin Pharmacol Ther 1975;18: 215-20.[Medline]
4. Cohen LS, Rosenthal JE, Horner DW Jr, Atkins JM, Matthews OA, Sarnoff SJ. Plasma levels of lidocaine after intramuscular administration. Am J Cardiol 1972;29: 520-3.[Medline]
5. Evans EF, Proctor JD, Fratkin MJ, Velandia J, Wasserman AJ. Blood flow in muscle groups and drug absorption. Clin Pharmacol Ther 1974;17: 44-7.
6. Grabinski PY. IM injections—deltoid or gluteal site? PRN Forum 1983;2: 2-3.[Medline]
7. Greenway, K. Using the ventrogluteal site for intramuscular injections. Nursing Standard 2004;18(25): 39-42.

(Accepted 21 November 2005)

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

Relevant Articles

Gluteal injections in increasingly obese population: Needle length for intramuscular injections

Brian J Anthony
BMJ 2006 332: 795. [Extract] [Full Text]

Gluteal injections in increasingly obese population: Essential considerations for intramuscular injections

Saurabh Rai and Nidhi Nandan
BMJ 2006 332: 795. [Extract] [Full Text]

Longer needles needed for gluteal intramuscular injections
BMJ 2006 332: 0. [Full Text]

This article has been cited by other articles:

• Bogin, B., Varela-Silva, M. I. (2008). Fatness biases the use of estimated leg length as an epidemiological marker for adults in the NHANES III sample. Int J Epidemiol 37: 201-209 [Abstract] [Full text]  
• (2006). Needles Falling Short in Obesity Epidemic. DOC News 3: 13-13 [Full text]  
• (2006). Intramuscular Injections in a Fatter Population. JWatch General 2006: 3-3 [Full text]  
• Anthony, B. J (2006). Gluteal injections in increasingly obese population: needle length for intramuscular injections.. BMJ 332: 795-795 [Full text]  
• Rai, S., Nandan, N. (2006). Gluteal injections in increasingly obese population: essential considerations for intramuscular injections.. BMJ 332: 795-795 [Full text]  

Rapid Responses:

Read all Rapid Responses

Complications of IM gluteal injections in obese population

Prasanta Padhan
bmj.com, 15 Mar 2006 [Full text]

"Must try harder"

Lewis G Morrison
bmj.com, 18 Mar 2006 [Full text]

Intramuscular Gluteal Injections; Do we need a longer needle?

Gautam Gulati
bmj.com, 17 Mar 2006 [Full text]

Time to Stop Gluteal Injection

Peter Hersey
bmj.com, 20 Mar 2006 [Full text]

Needle length for intramuscular injections

Brian J Anthony
bmj.com, 21 Mar 2006 [Full text]

Essential considerations for intramuscular injections

Saurabh Rai, et al.
bmj.com, 22 Mar 2006 [Full text]

Adipose tissue is compressible

Martin Stagg
bmj.com, 24 Mar 2006 [Full text]

Intramuscular injections into the buttocks: are they truly intramuscular?

Orla Buckley, et al.
bmj.com, 24 Mar 2006 [Full text]

inherently biased population

Effrossyni D Gkrania-Klotsas
bmj.com, 25 Mar 2006 [Full text]

"Intramuscular" Gluteal Injections

Leslie Michaels
bmj.com, 28 Mar 2006 [Full text]

Online poll

Find out more here>> and here>>